Clinical impact of the CPT1A p.P479L ‘Arctic variant’: Evidence for benefit, risk, and gaps in understanding

Ching-Hsi Chuang, Bojana Rakic, Graham Sinclair, Daniel L. Metzger, Sorcha A. Collins, Hilary Vallance, Cheryl Rockman-Greenberg, Laura Arbour

Open source

DOI
10.1016/j.ymgme.2026.110313
Published
2026-12
Container
Molecular Genetics and Metabolism
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.ymgme.2026.110313,
  title = {Clinical impact of the CPT1A p.P479L ‘Arctic variant’: Evidence for benefit, risk, and gaps in understanding},
  author = {Ching-Hsi Chuang and Bojana Rakic and Graham Sinclair and Daniel L. Metzger and Sorcha A. Collins and Hilary Vallance and Cheryl Rockman-Greenberg and Laura Arbour},
  year = {2026},
  journal = {Molecular Genetics and Metabolism},
  doi = {10.1016/j.ymgme.2026.110313},
  url = {https://doi.org/10.1016/j.ymgme.2026.110313}
}

RIS

TY  - JOUR
TI  - Clinical impact of the CPT1A p.P479L ‘Arctic variant’: Evidence for benefit, risk, and gaps in understanding
AU  - Ching-Hsi Chuang
AU  - Bojana Rakic
AU  - Graham Sinclair
AU  - Daniel L. Metzger
AU  - Sorcha A. Collins
AU  - Hilary Vallance
AU  - Cheryl Rockman-Greenberg
AU  - Laura Arbour
PY  - 2026
JO  - Molecular Genetics and Metabolism
DO  - 10.1016/j.ymgme.2026.110313
UR  - https://doi.org/10.1016/j.ymgme.2026.110313
ER  - 

APA

Chuang, C., Rakic, B., Sinclair, G., Metzger, D. L., Collins, S. A., Vallance, H., Rockman-Greenberg, C., & Arbour, L. (2026). Clinical impact of the CPT1A p.P479L ‘Arctic variant’: Evidence for benefit, risk, and gaps in understanding. Molecular Genetics and Metabolism. https://doi.org/10.1016/j.ymgme.2026.110313

Source records